886997886	886997886	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
84748264	84748264	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
020719	020719	CD	B-NP	O
|	|	CC	I-NP	O
5/17/1995	5/17/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/2/1995	9/2/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/21/1995	3/21/1995	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
42	42	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
variegate	variegate	NN	B-NP	O
porphyria	porphyria	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
experienced	experience	VBN	I-VP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
habits	habit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fatigue	fatigue	NN	B-NP	O
with	with	IN	B-PP	O
flashing	flash	VBG	B-VP	O
sensations	sensation	NNS	B-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
with	with	IN	B-PP	O
emotional	emotional	JJ	B-NP	O
lability	lability	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
variegate	variegate	NN	B-NP	O
porphyria	porphyria	NN	I-NP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
fifteen	fifteen	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nigel	Nigel	NNP	I-NP	O
Wickenhauser	Wickenhauser	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
relatively	relatively	RB	B-ADJP	O
free	free	JJ	I-ADJP	O
of	of	IN	B-PP	O
porphyria	porphyria	NN	B-NP	O
attacks	attack	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
major	major	JJ	I-NP	O
one	one	NN	I-NP	O
approximately	approximately	RB	B-NP	O
twelve	twelve	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
experiencing	experience	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
April	April	NNP	B-NP	O
1994	1994	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
porphyria	porphyria	NN	I-NP	O
attack	attack	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
stopping	stop	VBG	B-VP	O
all	all	PDT	B-NP	O
her	her	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
intermittently	intermittently	RB	B-ADVP	O
had	have	VBD	B-VP	O
skin	skin	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
with	with	IN	B-PP	O
sun	sun	NN	B-NP	O
exposure	exposure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
phlebotomized	phlebotomize	VBN	I-VP	O
or	or	CC	I-VP	O
received	receive	VBN	I-VP	O
other	other	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
Ativan	Ativan	NNP	B-NP	O
of	of	IN	B-PP	O
3-4	3-4	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
taking	take	VBG	I-VP	O
Ativan	Ativan	NNP	B-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
abrupt	abrupt	JJ	I-NP	O
stopping	stopping	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
feelings	feeling	NNS	B-NP	O
of	of	IN	B-PP	O
disorientation	disorientation	NN	B-NP	O
,	,	,	O	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fatigue	fatigue	NN	B-NP	O
with	with	IN	B-PP	O
emotional	emotional	JJ	B-NP	O
lability	lability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
Idaho	Idaho	NNP	B-NP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
sun	sun	NN	I-NP	O
exposure	exposure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
contacted	contact	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Furuya	Furuya	NNP	I-NP	O
who	who	WP	B-NP	O
advised	advise	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
intake	intake	NN	I-NP	O
to	to	TO	B-PP	O
about	about	IN	B-NP	O
400	400	CD	I-NP	O
grams	gram	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
progressed	progress	VBD	B-VP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
and	and	CC	O	O
while	while	IN	B-SBAR	O
standing	standing	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
gave	give	VBD	B-VP	O
way	way	NN	B-NP	O
without	without	IN	B-PP	O
losing	lose	VBG	B-VP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
felt	feel	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
vertigo	vertigo	NN	I-NP	O
,	,	,	O	O
tinnitus	tinnitus	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
ataxia	ataxia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
paresthesias	paresthesia	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hands	hand	NNS	I-NP	O
and	and	CC	I-NP	O
feet	foot	NNS	I-NP	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
perioral	perioral	JJ	I-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
experienced	experience	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
flushing	flushing	NN	B-NP	O
and	and	CC	I-NP	O
tremulousness	tremulousness	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
rushing	rush	VBG	B-VP	O
sensation	sensation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
associated	associate	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
symptomatology	symptomatology	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
flushing	flushing	NN	B-NP	O
and	and	CC	I-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
burning	burn	VBG	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
bouts	bout	NNS	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
intermingled	intermingle	VBN	B-VP	O
with	with	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
became	become	VBD	B-VP	O
confused	confuse	VBN	B-ADJP	O
and	and	CC	O	O
disoriented	disorient	VBN	B-VP	O
while	while	IN	B-SBAR	O
driving	drive	VBG	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Heyn	Heyn	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
VVH	VVH	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
porphyria	porphyria	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
new	new	JJ	I-NP	O
medications	medication	NNS	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
was	be	VBD	B-VP	O
chloral	chloral	JJ	B-NP	O
hydrate	hydrate	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
Compazine	Compazine	NN	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	NN	I-NP	O
descending	descend	VBG	B-VP	O
in	in	IN	B-PP	O
6/25	6/25	CD	B-NP	O
Exercise	Exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
before	before	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
1/10	1/10	CD	B-NP	O
for	for	IN	B-PP	O
angina	angina	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
patent	patent	NN	I-NP	O
LIMA	LIMA	NN	I-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NNP	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
cholestyramine	cholestyramine	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
ulna	ulna	NN	B-NP	O
entrapment	entrapment	NN	I-NP	O
release	release	NN	I-NP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
excisional	excisional	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
pathology	pathology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
diabetic	diabetic	JJ	B-NP	O
mastopathy	mastopathy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Morphine	Morphine	NN	B-NP	O
which	which	WDT	B-NP	O
gave	give	VBD	B-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
avoided	avoid	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
medications	medication	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
worsen	worsen	VB	I-VP	O
porphyria	porphyria	NN	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
sulfa	sulfa	NN	B-NP	O
drugs	drug	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
not	not	RB	O	O
allgergies	allgergy	NNS	B-NP	O
-RRB-	-RRB-	IN	B-PP	O
CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
took	take	VBD	B-VP	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
Regular	Regular	JJ	B-NP	B-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Compazine	Compazine	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
anxiety	anxiety	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
took	take	VBD	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chloral	chloral	JJ	B-NP	O
hydrate	hydrate	NN	I-NP	O
500	500	CD	B-NP	O
to	to	TO	I-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
married	marry	VBN	I-VP	O
for	for	IN	B-PP	O
fifteen	fifteen	CD	B-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
or	or	CC	I-NP	O
ethanol	ethanol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pale	pale	JJ	I-NP	O
and	and	CC	I-NP	O
anxious	anxious	JJ	I-NP	O
white	white	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
99.5	99.5	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
134/70	134/70	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
92	92	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
oropharynx	oropharynx	NN	B-NP	O
with	with	IN	B-PP	O
upper	upper	JJ	B-NP	O
dentures	denture	NNS	I-NP	O
and	and	CC	I-NP	O
sclerae	sclerae	NNS	I-NP	O
were	be	VBD	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thyroid	thyroid	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

BREASTS	BREASTS	NNS	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
fully	fully	RB	B-NP	O
healed	heal	VBN	I-NP	O
scar	scar	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
best	best	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
non-distended	non-distended	JJ	B-ADJP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
blister	blister	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hand	hand	NN	I-NP	O
fourth	fourth	JJ	I-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
digit	digit	NN	I-NP	O
interspace	interspace	NN	I-NP	O
and	and	CC	O	O
healed	heal	VBD	B-VP	O
lesions	lesion	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
.	.	.	O	O

NEUROLOGICAL	NEUROLOGICAL	NN	B-NP	O
:	:	:	O	O
Examination	Examination	NN	B-NP	O
showed	show	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
examination	examination	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
confusion	confusion	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
motor	motor	NN	B-NP	O
was	be	VBD	B-VP	O
symmetric	symmetric	JJ	B-ADJP	O
of	of	IN	B-PP	O
3-4/5	3-4/5	CD	B-NP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
muscle	muscle	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
sensory	sensory	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
decrease	decrease	NN	B-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
touch	touch	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
feet	foot	NNS	I-NP	O
and	and	CC	I-NP	O
hands	hand	NNS	I-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
symmetric	symmetric	JJ	B-ADJP	O
and	and	CC	O	O
1-2	1-2	CD	B-NP	O
+	+	SYM	I-NP	O
throughout	throughout	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coordination	coordination	NN	B-NP	O
showed	show	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
alternating	alternate	VBG	I-NP	O
movements	movement	NNS	I-NP	O
and	and	CC	I-NP	O
finger-to-nose	finger-to-nose	NN	I-NP	O
both	both	CC	B-PP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Gait	Gait	NNP	B-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
wide	wide	JJ	I-ADJP	O
based	base	VBN	B-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
heel-to-toe	heel-to-toe	JJ	I-NP	O
walk	walk	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Romberg	Romberg	NNP	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	B-protein
of	of	IN	B-PP	O
17	17	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
was	be	VBD	B-VP	O
364	364	CD	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
7.2	7.2	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
36	36	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
266	266	CD	B-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
porphyria	porphyria	NN	I-NP	O
attack	attack	NN	I-NP	O
versus	versus	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
versus	versus	CC	O	O
anxiety	anxiety	NN	B-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
longstanding	longstanding	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
but	but	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
symptomatology	symptomatology	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
porphyria	porphyria	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Psychiatry	Psychiatry	NN	B-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
anxiety	anxiety	NN	I-NP	O
disorder	disorder	NN	I-NP	O
separated	separate	VBN	B-VP	O
by	by	IN	B-PP	O
post	post	NN	B-NP	O
dysthymia	dysthymia	NN	I-NP	O
and	and	CC	O	O
suggested	suggest	VBN	B-NP	O
phenothiazines	phenothiazine	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
proven	prove	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
safe	safe	JJ	B-ADJP	O
in	in	IN	B-PP	O
porphyria	porphyria	NN	B-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Trilafon	Trilafon	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
to	to	TO	I-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
orthostatic	orthostatic	JJ	B-ADJP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	FW	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
hyperglycemic	hyperglycemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
orthostasis	orthostasis	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
held	hold	VBN	I-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
orthostasis	orthostasis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Watson-Schwartz	Watson-Schwartz	NNP	I-NP	O
test	test	NN	I-NP	O
done	do	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mohar	Mohar	NNP	I-NP	O
on	on	IN	B-PP	O
patient	patient	NN	B-NP	O
very	very	RB	B-ADVP	O
early	early	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
which	which	WDT	B-NP	O
made	make	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
porphyria	porphyria	NN	I-NP	O
attack	attack	NN	I-NP	O
very	very	RB	B-ADJP	O
unlikely	unlikely	JJ	I-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
were	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
attack	attack	NN	I-NP	O
and	and	CC	O	O
rapid	rapid	JJ	B-NP	O
taper	taper	NN	I-NP	O
of	of	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
at	at	IN	B-PP	O
moderately	moderately	RB	B-NP	O
high	high	JJ	I-NP	O
doses	dose	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
showed	show	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
E.	E.	NNP	B-NP	O
coli	coli	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
pansensitive	pansensitive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
safe	safe	JJ	B-ADJP	O
in	in	IN	B-PP	O
porphyria	porphyria	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
regular	regular	JJ	I-NP	I-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
Trilafon	Trilafon	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
and	and	CC	O	O
Keflex	Keflex	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dario	Dario	NNP	I-NP	O
Rodriquz	Rodriquz	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BERNARD	BERNARD	NNP	B-NP	O
SYPOLT	SYPOLT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD9	AD9	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JASPER	JASPER	NNP	B-NP	O
E.	E.	NNP	I-NP	O
FIDO	FIDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
NQ5	NQ5	NNP	I-NP	O
DL409/8702	DL409/8702	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
80499	80499	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

RRXZKL52AC	RRXZKL52AC	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/18/95	4/18/95	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/26/95	2/26/95	CD	B-NP	O
addendum	addendum	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
24	24	CD	I-NP	O
hour	hour	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
porphobilinogen	porphobilinogen	NN	I-NP	O
and	and	CC	O	O
delta-aminolevulinic	delta-aminolevulinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
were	be	VBD	B-VP	O
both	both	DT	O	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
corroborating	corroborate	VBG	B-VP	O
the	the	DT	B-NP	O
Watson	Watson	NNP	I-NP	O
Schwartz	Schwartz	NNP	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
porphyric	porphyric	JJ	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

gn24	gn24	NN	B-NP	O

